LakeShore Biopharma Co., Ltd (LSB)
USD 1.19
(-4.8%)
USD 1.19
(-4.8%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -368.66 Million CNY | -180.79% |
| 2022 | -76.8 Million CNY | -13888.4% |
| 2021 | -67.19 Million CNY | 99.53% |
| 2020 | -116.77 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q4 | -11.44 Million USD | 3.69% |
| 2023 FY | - CNY | -180.79% |
| 2023 Q3 | -11.87 Million USD | 87.94% |
| 2023 Q2 | -98.47 Million CNY | -43.15% |
| 2023 Q1 | -68.79 Million CNY | -749.7% |
| 2022 Q3 | -5.84 Million USD | -1629.4% |
| 2022 Q1 | -410.67 Thousand USD | -75.73% |
| 2022 Q2 | 382.27 Thousand USD | 193.09% |
| 2022 FY | - CNY | -13888.4% |
| 2022 Q4 | -8.09 Million USD | -38.48% |
| 2021 Q1 | -40.33 Thousand USD | 0.0% |
| 2021 FY | - CNY | 99.53% |
| 2021 Q4 | -233.7 Thousand USD | 22.7% |
| 2021 Q3 | -302.31 Thousand USD | -48.99% |
| 2021 Q2 | -202.9 Thousand USD | -403.1% |
| 2020 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Sangamo Therapeutics, Inc. | -87.42 Million USD | -321.681% |
| IDEAYA Biosciences, Inc. | -130.42 Million USD | -182.672% |
| Eton Pharmaceuticals, Inc. | -291 Thousand USD | -126588.415% |
| Autolus Therapeutics plc | -156.77 Million USD | -135.162% |
| Greenwich LifeSciences, Inc. | -9.32 Million USD | -3853.81% |
| Enlivex Therapeutics Ltd. | -28.21 Million USD | -1206.436% |
| Shattuck Labs, Inc. | -87.61 Million USD | -320.776% |
| LENZ Therapeutics, Inc. | -122.24 Million USD | -201.58% |
| CervoMed Inc. | -2.17 Million USD | -16874.433% |
| Rocket Pharmaceuticals, Inc. | -236.62 Million USD | -55.803% |
| Corbus Pharmaceuticals Holdings, Inc. | -44.43 Million USD | -729.637% |
| Aptose Biosciences Inc. | -52.26 Million USD | -605.333% |
| Precision BioSciences, Inc. | -32.04 Million USD | -1050.563% |
| Dyadic International, Inc. | -8.22 Million USD | -4379.647% |
| TScan Therapeutics, Inc. | -80.09 Million USD | -360.265% |
| Intensity Therapeutics, Inc. | -10.08 Million USD | -3555.198% |
| Nektar Therapeutics | -243.1 Million USD | -51.647% |
| CytomX Therapeutics, Inc. | -4.3 Million USD | -8455.658% |
| VYNE Therapeutics Inc. | -29.25 Million USD | -1160.043% |
| EyePoint Pharmaceuticals, Inc. | -69 Million USD | -434.287% |
| Leap Therapeutics, Inc. | -80.98 Million USD | -355.213% |
| Adaptive Biotechnologies Corporation | -189.27 Million USD | -94.779% |
| GRI Bio, Inc. | -10.89 Million USD | -3282.853% |
| Xenetic Biosciences, Inc. | -4.51 Million USD | -8064.007% |
| Tenaya Therapeutics, Inc. | -122.5 Million USD | -200.935% |
| NeuroSense Therapeutics Ltd. | -10.63 Million USD | -3367.162% |
| Psyence Biomedical Ltd. | -2.75 Million USD | -13298.24% |
| IGM Biosciences, Inc. | -253.35 Million USD | -45.511% |
| INmune Bio, Inc. | - USD | Infinity% |
| Opthea Limited | -200.01 Million USD | -84.314% |
| Milestone Pharmaceuticals Inc. | -56.84 Million USD | -548.541% |
| Omega Therapeutics, Inc. | -93.49 Million USD | -294.334% |
| Verastem, Inc. | -83.16 Million USD | -343.286% |
| Abeona Therapeutics Inc. | -50.57 Million USD | -628.987% |
| Pliant Therapeutics, Inc. | -158.22 Million USD | -132.995% |
| Tonix Pharmaceuticals Holding Corp. | -114.08 Million USD | -223.137% |
| Ligand Pharmaceuticals Incorporated | 101.72 Million USD | 462.405% |
| NextCure, Inc. | -59.03 Million USD | -524.44% |
| Inhibikase Therapeutics, Inc. | -19.91 Million USD | -1751.426% |
| Organovo Holdings, Inc. | -14.8 Million USD | -2389.959% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 11495681.135% |
| Arvinas, Inc. | -394.8 Million USD | 6.62% |
| Ovid Therapeutics Inc. | -58.71 Million USD | -527.905% |
| CASI Pharmaceuticals, Inc. | -21.53 Million USD | -1611.608% |
| Rani Therapeutics Holdings, Inc. | -65.27 Million USD | -464.768% |
| Centessa Pharmaceuticals plc | -166.06 Million USD | -121.998% |
| Arcturus Therapeutics Holdings Inc. | -24.16 Million USD | -1425.545% |
| Syros Pharmaceuticals, Inc. | -157.19 Million USD | -134.526% |
| Senti Biosciences, Inc. | -61.33 Million USD | -501.055% |
| BioRestorative Therapies, Inc. | -15.05 Million USD | -2348.77% |
| Apollomics, Inc. | -171.74 Million USD | -114.655% |
| PureTech Health plc | -11.62 Million USD | -3070.752% |
| Oncternal Therapeutics, Inc. | 2.23 Million USD | 16595.002% |
| Barinthus Biotherapeutics plc | -74.81 Million USD | -392.767% |
| Kymera Therapeutics, Inc. | -143.2 Million USD | -157.445% |
| Synaptogenix, Inc. | -8.3 Million USD | -4337.713% |
| ChromaDex Corporation | -3.89 Million USD | -9367.47% |
| Beam Therapeutics Inc. | -156.47 Million USD | -135.608% |
| Monopar Therapeutics Inc. | 429.03 Thousand USD | 86027.687% |
| Akebia Therapeutics, Inc. | -6.86 Million USD | -5267.841% |
| Nurix Therapeutics, Inc. | -141.4 Million USD | -160.707% |
| Apellis Pharmaceuticals, Inc. | -495.21 Million USD | 25.554% |
| Dermata Therapeutics, Inc. | 247.21 Thousand USD | 149225.982% |
| Gritstone bio, Inc. | -126.86 Million USD | -190.6% |
| Mesoblast Limited | -61.33 Million USD | -501.104% |
| Virpax Pharmaceuticals, Inc. | -2.24 Million USD | -16287.082% |
| Xeris Biopharma Holdings, Inc. | -23.73 Million USD | -1453.247% |
| Fate Therapeutics, Inc. | -172.22 Million USD | -114.054% |
| MediWound Ltd. | -4.89 Million USD | -7434.504% |
| BioXcel Therapeutics, Inc. | -165.42 Million USD | -122.864% |
| Fortress Biotech, Inc. | -133.64 Million USD | -175.857% |
| Fractyl Health, Inc. Common Stock | -50.55 Million USD | -629.304% |
| Achilles Therapeutics plc | -70.44 Million USD | -423.357% |
| Seres Therapeutics, Inc. | -85.43 Million USD | -331.518% |
| Checkpoint Therapeutics, Inc. | -52.14 Million USD | -606.956% |
| Atossa Therapeutics, Inc. | -31.35 Million USD | -1075.809% |
| Zai Lab Limited | -366.57 Million USD | -0.57% |
| Fresh Tracks Therapeutics, Inc. | -5.64 Million USD | -6427.324% |
| Lyell Immunopharma, Inc. | -225.24 Million USD | -63.669% |
| Vanda Pharmaceuticals Inc. | -10.94 Million USD | -3269.25% |
| Tarsus Pharmaceuticals, Inc. | -131.67 Million USD | -179.99% |
| InMed Pharmaceuticals Inc. | -7.06 Million USD | -5118.954% |
| FibroGen, Inc. | -261.4 Million USD | -41.031% |
| Celcuity Inc. | -58.3 Million USD | -532.248% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3209.068% |
| ContextLogic Inc. | -324 Million USD | -13.785% |
| GH Research PLC | -41.15 Million USD | -795.836% |
| HOOKIPA Pharma Inc. | -77.34 Million USD | -376.66% |
| Cyclacel Pharmaceuticals, Inc. | -25.42 Million USD | -1350.174% |
| ImmuCell Corporation | -2.5 Million USD | -14622.522% |
| Amylyx Pharmaceuticals, Inc. | 39.89 Million USD | 1024.2% |
| Amarin Corporation plc | -50.9 Million USD | -624.268% |
| TG Therapeutics, Inc. | 26.1 Million USD | 1512.503% |
| Aptevo Therapeutics Inc. | -28.31 Million USD | -1202.191% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -467.305% |
| Foghorn Therapeutics Inc. | -104.45 Million USD | -252.94% |
| Y-mAbs Therapeutics, Inc. | -25.67 Million USD | -1336.052% |
| Aptorum Group Limited | -9.59 Million USD | -3740.644% |
| Ultragenyx Pharmaceutical Inc. | -516.45 Million USD | 28.616% |
| BioCryst Pharmaceuticals, Inc. | -116.33 Million USD | -216.898% |
| Chemomab Therapeutics Ltd. | -25.39 Million USD | -1351.888% |
| Arrowhead Pharmaceuticals, Inc. | -175.67 Million USD | -109.859% |
| TransCode Therapeutics, Inc. | -17.97 Million USD | -1951.155% |
| RAPT Therapeutics, Inc. | -125.84 Million USD | -192.948% |
| Ardelyx, Inc. | -55.35 Million USD | -566.01% |
| Ainos, Inc. | -8.77 Million USD | -4102.202% |
| Lyra Therapeutics, Inc. | -65.25 Million USD | -465.001% |
| Prothena Corporation plc | -190.1 Million USD | -93.923% |
| HilleVax, Inc. | -132.46 Million USD | -178.308% |
| Adaptimmune Therapeutics plc | -128.19 Million USD | -187.573% |
| Celularity Inc. | -183.94 Million USD | -100.419% |
| Rallybio Corporation | -72.37 Million USD | -409.393% |
| Cue Biopharma, Inc. | -46.05 Million USD | -700.537% |
| Omeros Corporation | -163.61 Million USD | -125.331% |
| Humacyte, Inc. | -96.45 Million USD | -282.201% |
| Immunocore Holdings plc | -59.64 Million USD | -518.054% |
| Cocrystal Pharma, Inc. | -19.37 Million USD | -1803.073% |
| Blueprint Medicines Corporation | -474.61 Million USD | 22.323% |
| IO Biotech, Inc. | -91.22 Million USD | -304.112% |
| MEI Pharma, Inc. | 26.38 Million USD | 1497.511% |
| GT Biopharma, Inc. | 5.97 Million USD | 6265.969% |
| Cabaletta Bio, Inc. | -73.23 Million USD | -403.405% |
| Summit Therapeutics Inc. | 1 Million USD | 36929.499% |
| Alaunos Therapeutics, Inc. | -30.9 Million USD | -1092.931% |
| Marinus Pharmaceuticals, Inc. | -125.49 Million USD | -193.763% |
| Scholar Rock Holding Corporation | -168.45 Million USD | -118.855% |
| Pulmatrix, Inc. | -12.64 Million USD | -2815.256% |
| Elicio Therapeutics, Inc. | -32.96 Million USD | -1018.314% |
| X4 Pharmaceuticals, Inc. | -107.1 Million USD | -244.214% |
| Vigil Neuroscience, Inc. | -88.46 Million USD | -316.724% |
| Acelyrin, Inc. | -381.52 Million USD | 3.371% |
| Intellia Therapeutics, Inc. | -506.31 Million USD | 27.187% |
| Cytokinetics, Incorporated | -456.68 Million USD | 19.274% |
| Vor Biopharma Inc. | -114.37 Million USD | -222.34% |
| Evogene Ltd. | -23.2 Million USD | -1488.792% |
| Replimune Group, Inc. | -230.19 Million USD | -60.151% |
| Applied Therapeutics, Inc. | -64.53 Million USD | -471.261% |
| PDS Biotechnology Corporation | -40.08 Million USD | -819.705% |
| Hoth Therapeutics, Inc. | -153.14 Thousand USD | -240621.968% |
| BridgeBio Pharma, Inc. | -565.46 Million USD | 34.804% |
| AEON Biopharma, Inc. | -48.36 Million USD | -662.315% |
| BioLineRx Ltd. | -57.06 Million USD | -546.086% |
| Galectin Therapeutics Inc. | -202 Thousand USD | -182406.578% |
| Atai Life Sciences N.V. | -36.31 Million USD | -915.294% |
| Aerovate Therapeutics, Inc. | -81.31 Million USD | -353.388% |
| VistaGen Therapeutics, Inc. | -32.45 Million USD | -1035.991% |
| Zentalis Pharmaceuticals, Inc. | -275.5 Million USD | -33.815% |
| Sagimet Biosciences Inc. | -30.74 Million USD | -1099.295% |
| MediciNova, Inc. | -9.87 Million USD | -3631.421% |
| Praxis Precision Medicines, Inc. | -125.94 Million USD | -192.727% |
| MiMedx Group, Inc. | 40.51 Million USD | 1009.898% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -23992.475% |
| Axsome Therapeutics, Inc. | -224.99 Million USD | -63.857% |
| PTC Therapeutics, Inc. | -330.34 Million USD | -11.601% |
| Mereo BioPharma Group plc | -26.05 Million USD | -1314.888% |
| Syndax Pharmaceuticals, Inc. | -229.94 Million USD | -60.329% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1127.854% |
| Dyne Therapeutics, Inc. | -233.47 Million USD | -57.902% |
| BriaCell Therapeutics Corp. | -4.79 Million USD | -7594.165% |
| Allakos Inc. | -189.91 Million USD | -94.12% |
| scPharmaceuticals Inc. | -46.06 Million USD | -700.381% |
| Fulcrum Therapeutics, Inc. | -108.49 Million USD | -239.807% |
| Corcept Therapeutics Incorporated | 108.32 Million USD | 440.334% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3025.416% |
| Precigen, Inc. | -89.22 Million USD | -313.179% |
| XOMA Corporation | -39.36 Million USD | -836.597% |
| Kezar Life Sciences, Inc. | -99.25 Million USD | -271.434% |
| Incyte Corporation | 919.42 Million USD | 140.097% |
| Alzamend Neuro, Inc. | -9.88 Million USD | -3628.804% |
| Cara Therapeutics, Inc. | -117.65 Million USD | -213.356% |
| Aligos Therapeutics, Inc. | -83.81 Million USD | -339.854% |
| Seer, Inc. | -97.88 Million USD | -276.629% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1428.968% |
| CRISPR Therapeutics AG | -202.7 Million USD | -81.875% |
| Akero Therapeutics, Inc. | -148.63 Million USD | -148.039% |
| Eliem Therapeutics, Inc. | -13.65 Million USD | -2600.236% |
| EyeGate Pharmaceuticals, Inc. | -8.04 Million USD | -4484.053% |
| Akari Therapeutics, Plc | -16.8 Million USD | -2094.163% |
| Novavax, Inc. | -487.39 Million USD | 24.36% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5670.62% |
| UroGen Pharma Ltd. | -63.83 Million USD | -477.562% |
| Sutro Biopharma, Inc. | -67.91 Million USD | -442.83% |
| Entera Bio Ltd. | -8.8 Million USD | -4087.452% |
| Lisata Therapeutics, Inc. | -25.51 Million USD | -1344.662% |
| Stoke Therapeutics, Inc. | -112.3 Million USD | -228.273% |
| Chimerix, Inc. | -92.97 Million USD | -296.523% |
| Reneo Pharmaceuticals, Inc. | -82.23 Million USD | -348.316% |
| Phathom Pharmaceuticals, Inc. | -159.04 Million USD | -131.792% |
| Outlook Therapeutics, Inc. | -57.37 Million USD | -542.54% |
| Jazz Pharmaceuticals plc | 1.44 Billion USD | 125.435% |
| AnaptysBio, Inc. | -143.16 Million USD | -157.511% |
| Aprea Therapeutics, Inc. | -14.27 Million USD | -2481.728% |
| Portage Biotech Inc. | -18.19 Million USD | -1925.734% |
| Olema Pharmaceuticals, Inc. | -104.58 Million USD | -252.504% |
| PMV Pharmaceuticals, Inc. | -78.87 Million USD | -367.402% |
| OKYO Pharma Limited | -15.74 Thousand USD | -2341233.232% |
| Qualigen Therapeutics, Inc. | -11.3 Million USD | -3162.402% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.33 Million USD | -4321.481% |
| Processa Pharmaceuticals, Inc. | -11.45 Million USD | -3117.845% |
| AbCellera Biologics Inc. | -192.15 Million USD | -91.854% |
| Genprex, Inc. | -31.06 Million USD | -1086.917% |
| Neumora Therapeutics, Inc. Common Stock | -187.52 Million USD | -96.593% |
| NLS Pharmaceutics AG | -11.79 Million USD | -3025.416% |
| Virios Therapeutics, Inc. | 150.9 Thousand USD | 244403.191% |
| Daré Bioscience, Inc. | -30.7 Million USD | -1100.798% |
| Titan Pharmaceuticals, Inc. | -7.16 Million USD | -5045.335% |
| Bicycle Therapeutics plc | -183.4 Million USD | -101.016% |
| Revolution Medicines, Inc. Warrant | -430.58 Million USD | 14.38% |
| Protagonist Therapeutics, Inc. | -90.34 Million USD | -308.084% |
| Erasca, Inc. | -121.31 Million USD | -203.902% |
| bluebird bio, Inc. | -167.16 Million USD | -120.544% |
| Pieris Pharmaceuticals, Inc. | -22.76 Million USD | -1519.644% |
| BioMarin Pharmaceutical Inc. | 310.28 Million USD | 218.815% |
| DBV Technologies S.A. | -85.98 Million USD | -328.768% |
| Fortress Biotech, Inc. | -133.64 Million USD | -175.857% |
| Avidity Biosciences, Inc. | -233.49 Million USD | -57.888% |
| CorMedix Inc. | -48.88 Million USD | -654.113% |
| Travere Therapeutics, Inc. | -326.24 Million USD | -13.002% |
| Sensei Biotherapeutics, Inc. | -33.38 Million USD | -1004.245% |
| Orchestra BioMed Holdings, Inc. | -51.21 Million USD | -619.778% |
| Spruce Biosciences, Inc. | -47.36 Million USD | -678.329% |
| Celldex Therapeutics, Inc. | -139.03 Million USD | -165.161% |
| Cartesian Therapeutics, Inc. | -235.06 Million USD | -56.835% |
| Cogent Biosciences, Inc. | -205.86 Million USD | -79.084% |
| Onconetix, Inc. | -36.7 Million USD | -904.348% |
| Ocuphire Pharma, Inc. | -9.96 Million USD | -3598.468% |
| Prime Medicine, Inc. | -193.75 Million USD | -90.269% |
| Adagene Inc. | -14.95 Million USD | -2365.846% |
| Inhibrx Biosciences, Inc. | -206.69 Million USD | -78.363% |
| GlycoMimetics, Inc. | -39.12 Million USD | -842.343% |
| Maravai LifeSciences Holdings, Inc. | 712.4 Million USD | 151.749% |
| Verve Therapeutics, Inc. | -217.66 Million USD | -69.369% |
| Voyager Therapeutics, Inc. | 126.45 Million USD | 391.537% |
| SciSparc Ltd. | -5.28 Million USD | -6879.615% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -387118.812% |
| Minerva Neurosciences, Inc. | -21.69 Million USD | -1599.58% |
| Astria Therapeutics, Inc. | -83.03 Million USD | -344.012% |
| Spero Therapeutics, Inc. | 27.15 Million USD | 1457.676% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 195463.84% |
| Arcutis Biotherapeutics, Inc. | -227.43 Million USD | -62.097% |
| Marker Therapeutics, Inc. | -11.79 Million USD | -3026.313% |
| Alnylam Pharmaceuticals, Inc. | -258.24 Million USD | -42.759% |
| Artelo Biosciences, Inc. | -10.28 Million USD | -3484.475% |
| 2seventy bio, Inc. | -206.41 Million USD | -78.6% |
| ADMA Biologics, Inc. | 5.12 Million USD | 7300.455% |
| Clene Inc. | -43.24 Million USD | -752.578% |
| Capricor Therapeutics, Inc. | -23 Million USD | -1502.258% |
| Boundless Bio, Inc. Common Stock | -48.47 Million USD | -660.491% |
| Recursion Pharmaceuticals, Inc. | -299.56 Million USD | -23.066% |
| Citius Pharmaceuticals, Inc. | -36.72 Million USD | -903.729% |
| Contineum Therapeutics, Inc. Class A Common Stock | 23.57 Million USD | 1663.922% |
| Absci Corporation | -95.45 Million USD | -286.209% |
| Regeneron Pharmaceuticals, Inc. | 4.65 Billion USD | 107.921% |
| Surrozen, Inc. | -41.13 Million USD | -796.315% |
| Caribou Biosciences, Inc. | -112.53 Million USD | -227.602% |
| Janux Therapeutics, Inc. | -71.02 Million USD | -419.069% |
| Cingulate Inc. | -22.95 Million USD | -1506.234% |
| Galmed Pharmaceuticals Ltd. | -7.46 Million USD | -4841.205% |
| Tenax Therapeutics, Inc. | -8.22 Million USD | -4381.481% |
| Jaguar Health, Inc. | -33.13 Million USD | -1012.744% |
| Terns Pharmaceuticals, Inc. | -102.26 Million USD | -260.494% |
| ACADIA Pharmaceuticals Inc. | -67.82 Million USD | -443.535% |
| Kronos Bio, Inc. | -121.83 Million USD | -202.605% |
| Innoviva, Inc. | 248.96 Million USD | 248.081% |
| Bolt Biotherapeutics, Inc. | -74.34 Million USD | -395.902% |
| Entrada Therapeutics, Inc. | -321 Thousand USD | -114748.376% |
| ZyVersa Therapeutics, Inc. | -107.74 Million USD | -242.168% |
| Soligenix, Inc. | -7.85 Million USD | -4594.643% |
| AlloVir, Inc. | -190.14 Million USD | -93.884% |
| Century Therapeutics, Inc. | -121.2 Million USD | -204.158% |
| ORIC Pharmaceuticals, Inc. | -109.74 Million USD | -235.918% |
| Kura Oncology, Inc. | -164.95 Million USD | -123.493% |
| Ocean Biomedical, Inc. | -957.73 Thousand USD | -38393.085% |
| Mineralys Therapeutics, Inc. | -84.65 Million USD | -335.479% |
| Eterna Therapeutics Inc. | -19.93 Million USD | -1749.42% |
| SELLAS Life Sciences Group, Inc. | 529 Thousand USD | 69790.602% |
| Heron Therapeutics, Inc. | -103.79 Million USD | -255.194% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -866.777% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2304.706% |
| Entero Therapeutics, Inc. | -15.74 Million USD | -2241.724% |
| HCW Biologics Inc. | -23.57 Million USD | -1463.719% |
| C4 Therapeutics, Inc. | -122.1 Million USD | -201.928% |
| Atara Biotherapeutics, Inc. | -265.99 Million USD | -38.597% |
| Coherus BioSciences, Inc. | -193.93 Million USD | -90.092% |
| Lantern Pharma Inc. | -15.78 Million USD | -2235.279% |
| Histogen Inc. | -10.5 Million USD | -3410.076% |
| Surrozen, Inc. | -41.13 Million USD | -796.315% |
| Eledon Pharmaceuticals, Inc. | - USD | Infinity% |
| Kodiak Sciences Inc. | -259.02 Million USD | -42.328% |
| MoonLake Immunotherapeutics | -54.1 Million USD | -581.323% |
| Hepion Pharmaceuticals, Inc. | -49.25 Million USD | -648.426% |
| Adverum Biotechnologies, Inc. | -112.59 Million USD | -227.413% |
| Avalo Therapeutics, Inc. | -27.95 Million USD | -1218.774% |
| Moderna, Inc. | -3.28 Billion USD | 88.771% |
| Ionis Pharmaceuticals, Inc. | -230.01 Million USD | -60.281% |
| Turnstone Biologics Corp. | -56.23 Million USD | -555.588% |
| Immix Biopharma, Inc. | -16.13 Million USD | -2184.776% |
| Tiziana Life Sciences Ltd | -15.33 Million USD | -2303.438% |
| Aurinia Pharmaceuticals Inc. | -63.04 Million USD | -484.744% |
| Exelixis, Inc. | 196.6 Million USD | 287.518% |
| Monte Rosa Therapeutics, Inc. | -137.08 Million USD | -168.923% |
| Wave Life Sciences Ltd. | -58.79 Million USD | -527.085% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -113684.965% |
| Alkermes plc | 495.04 Million USD | 174.47% |
| Jasper Therapeutics, Inc. | -64.98 Million USD | -467.305% |
| Arcellx, Inc. | -64.14 Million USD | -474.734% |
| ESSA Pharma Inc. | -26.45 Million USD | -1293.532% |
| TNF Pharmaceuticals, Inc. | -3.99 Million USD | -9116.707% |
| Avid Bioservices, Inc. | -11.48 Million USD | -3111.073% |
| Insmed Incorporated | -654.73 Million USD | 43.693% |
| Cardiff Oncology, Inc. | -45.01 Million USD | -718.997% |
| Enanta Pharmaceuticals, Inc. | -123.47 Million USD | -198.571% |
| Moolec Science SA | -52.07 Million USD | -607.939% |
| RenovoRx, Inc. | -11.39 Million USD | -3136.728% |
| Acumen Pharmaceuticals, Inc. | -51.6 Million USD | -614.381% |
| Geron Corporation | -174.78 Million USD | -110.927% |
| LAVA Therapeutics N.V. | -40.41 Million USD | -812.149% |
| Verrica Pharmaceuticals Inc. | -62.19 Million USD | -492.735% |
| Royalty Pharma plc | 1.88 Billion USD | 119.534% |
| OmniAb, Inc. | -49.73 Million USD | -641.315% |
| Alector, Inc. | -142.89 Million USD | -158.001% |
| Atea Pharmaceuticals, Inc. | -119.59 Million USD | -208.265% |
| Mersana Therapeutics, Inc. | -166.08 Million USD | -121.979% |
| Humacyte, Inc. | -96.45 Million USD | -282.201% |
| Structure Therapeutics Inc. | -102.45 Million USD | -259.815% |
| Revance Therapeutics, Inc. | -290.63 Million USD | -26.847% |
| 89bio, Inc. | -134.46 Million USD | -174.175% |
| Avenue Therapeutics, Inc. | 4.05 Million USD | 9198.304% |
| Aura Biosciences, Inc. | -83.69 Million USD | -340.479% |
| Immunic, Inc. | -99.11 Million USD | -271.966% |
| Veracyte, Inc. | -49.4 Million USD | -646.146% |
| Genelux Corporation | -24.16 Million USD | -1425.608% |
| Trevi Therapeutics, Inc. | -33.8 Million USD | -990.72% |
| Adial Pharmaceuticals, Inc. | -7 Million USD | -5165.619% |
| Sonnet BioTherapeutics Holdings, Inc. | -18.71 Million USD | -1869.685% |
| Immunovant, Inc. | -269.97 Million USD | -36.553% |
| Vericel Corporation | 2.86 Million USD | 12972.321% |
| Fortrea Holdings Inc. | 167.3 Million USD | 320.361% |
| KalVista Pharmaceuticals, Inc. | -134.28 Million USD | -174.548% |
| XBiotech Inc. | -35.76 Million USD | -930.765% |
| Agenus Inc. | -145.92 Million USD | -152.641% |
| Acasti Pharma Inc. | -11.3 Million USD | -3162.218% |
| Kiora Pharmaceuticals, Inc. | -12.35 Million USD | -2885.122% |
| MiNK Therapeutics, Inc. | -22.25 Million USD | -1556.672% |
| Pasithea Therapeutics Corp. | -15.33 Million USD | -2304.706% |
| Theravance Biopharma, Inc. | -40.86 Million USD | -802.105% |
| Metagenomi, Inc. Common Stock | -56.02 Million USD | -558.081% |
| NeuroBo Pharmaceuticals, Inc. | -15.88 Million USD | -2221.557% |
| Gain Therapeutics, Inc. | -22.16 Million USD | -1562.926% |
| Tempest Therapeutics, Inc. | -28.77 Million USD | -1181.148% |
| Sol-Gel Technologies Ltd. | -28.96 Million USD | -1172.877% |
| Rhythm Pharmaceuticals, Inc. | -168.46 Million USD | -118.838% |
| United Therapeutics Corporation | 1.38 Billion USD | 126.584% |
| Creative Medical Technology Holdings, Inc. | -5.52 Million USD | -6571.977% |
| BriaCell Therapeutics Corp. | -4.77 Million USD | -7625.978% |
| Lixte Biotechnology Holdings, Inc. | 3207.00 USD | 11495681.135% |
| Silo Pharma, Inc. | -3.62 Million USD | -10066.617% |
| Telomir Pharmaceuticals, Inc. Common Stock | -6.11 Million USD | -5927.312% |
| Pharming Group N.V. | 9.87 Million USD | 3832.543% |
| XOMA Corporation | -39.36 Million USD | -836.597% |
| Reviva Pharmaceuticals Holdings, Inc. | -24.11 Million USD | -1428.968% |
| Bionomics Limited | -9.83 Million USD | -3647.723% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -965.316% |
| Pyxis Oncology, Inc. | -78.49 Million USD | -369.677% |
| uniQure N.V. | -253.1 Million USD | -45.659% |
| Xilio Therapeutics, Inc. | -73.8 Million USD | -399.517% |
| Cassava Sciences, Inc. | -95.68 Million USD | -285.28% |
| 60 Degrees Pharmaceuticals, Inc. | -1.42 Million USD | -25743.089% |
| Windtree Therapeutics, Inc. | -20.15 Million USD | -1728.778% |
| Poseida Therapeutics, Inc. | -129.5 Million USD | -184.673% |
| Pluri Inc. | -20.22 Million USD | -1722.81% |
| Anebulo Pharmaceuticals, Inc. | -8.05 Million USD | -4479.399% |
| MeiraGTx Holdings plc | -57.05 Million USD | -546.188% |
| Cidara Therapeutics, Inc. | -24.36 Million USD | -1413.086% |
| ProMIS Neurosciences, Inc. | -17.8 Million USD | -1970.016% |
| CalciMedica, Inc. | -34.18 Million USD | -978.31% |
| Sana Biotechnology, Inc. | -252.39 Million USD | -46.069% |
| Amicus Therapeutics, Inc. | -92.07 Million USD | -300.377% |
| Salarius Pharmaceuticals, Inc. | -12.88 Thousand USD | -2861106.32% |
| Alpha Tau Medical Ltd. | -34.6 Million USD | -965.316% |
| Adlai Nortye Ltd. American Depositary Shares | -101.21 Million USD | -264.238% |
| Nutriband Inc. | -5.12 Million USD | -7097.957% |
| Protara Therapeutics, Inc. | -43.27 Million USD | -751.967% |
| Compugen Ltd. | -12.51 Million USD | -2845.536% |
| Roivant Sciences Ltd. | -996.51 Million USD | 63.005% |
| ProKidney Corp. | -147.66 Million USD | -149.655% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8094.783% |
| Elevai Labs, Inc. Common Stock | -4.27 Million USD | -8533.107% |
| Tango Therapeutics, Inc. | -111.75 Million USD | -229.876% |
| Renovaro Biosciences Inc. | -79.51 Million USD | -363.628% |
| Zevra Therapeutics, Inc. | -48.59 Million USD | -658.598% |
| Benitec Biopharma Inc. | -22.49 Million USD | -1539.232% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1282.378% |
| Biomea Fusion, Inc. | -124.62 Million USD | -195.83% |
| Cullinan Oncology, Inc. | -190.33 Million USD | -93.688% |
| 4D Molecular Therapeutics, Inc. | -107.11 Million USD | -244.166% |
| Kiniksa Pharmaceuticals, Ltd. | -22.85 Million USD | -1513.053% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | -1510.094% |
| Spyre Therapeutics, Inc. | -242.3 Million USD | -52.15% |
| Ventyx Biosciences, Inc. | -207.83 Million USD | -77.382% |
| Imunon, Inc. | -19.87 Million USD | -1754.604% |
| BioAtla, Inc. | -122.24 Million USD | -201.587% |
| Allogene Therapeutics, Inc. | -300.29 Million USD | -22.768% |
| Larimar Therapeutics, Inc. | -41.44 Million USD | -789.481% |
| Zura Bio Limited | -60.56 Million USD | -508.727% |
| aTyr Pharma, Inc. | -52.17 Million USD | -606.549% |
| Madrigal Pharmaceuticals, Inc. | -379.96 Million USD | 2.975% |
| Viridian Therapeutics, Inc. | -234.56 Million USD | -57.169% |
| Galecto, Inc. | -37.51 Million USD | -882.604% |
| Tevogen Bio Holdings Inc. | 188.7 Thousand USD | 195463.84% |
| Halozyme Therapeutics, Inc. | 451.94 Million USD | 181.572% |
| Lexicon Pharmaceuticals, Inc. | -163.46 Million USD | -125.532% |
| PolyPid Ltd. | -20.26 Million USD | -1719.391% |
| Aileron Therapeutics, Inc. | -15.61 Million USD | -2261.258% |
| Forte Biosciences, Inc. | -32.47 Million USD | -1035.152% |
| Xencor, Inc. | -125.87 Million USD | -192.883% |
| Coeptis Therapeutics Holdings, Inc. | -20.15 Million USD | -1728.903% |
| Lexaria Bioscience Corp. | -6.38 Million USD | -5670.62% |
| Instil Bio, Inc. | -146.12 Million USD | -152.298% |
| Cardio Diagnostics Holdings, Inc. | -1.53 Million USD | -23992.475% |
| OncoCyte Corporation | -23.12 Million USD | -1494.358% |
| Elevation Oncology, Inc. | -41.46 Million USD | -789.052% |
| Purple Biotech Ltd. | -22.22 Million USD | -1558.777% |
| CollPlant Biotechnologies Ltd. | -6.41 Million USD | -5651.377% |
| MacroGenics, Inc. | 2.01 Million USD | 18377.803% |
| Verona Pharma plc | -52.46 Million USD | -602.65% |
| Tharimmune, Inc. | -9.3 Million USD | -3863.018% |
| Apogee Therapeutics, Inc. | -83.98 Million USD | -338.963% |
| enGene Holdings Inc. Warrants | -94.77 Million USD | -289.0% |
| Aditxt, Inc. | -25.45 Million USD | -1348.126% |
| XTL Biopharmaceuticals Ltd. | -764 Thousand USD | -48154.357% |
| Savara Inc. | -59.13 Million USD | -523.448% |
| Curis, Inc. | -45.13 Million USD | -716.729% |
| Carmell Therapeutics Corporation | -15.19 Million USD | -2326.83% |
| Achieve Life Sciences, Inc. | -26.73 Million USD | -1279.005% |
| BeiGene, Ltd. | -1.12 Billion USD | 67.219% |
| Protagenic Therapeutics, Inc. | -4.49 Million USD | -8094.783% |
| Vincerx Pharma, Inc. | -42.6 Million USD | -765.224% |
| Plus Therapeutics, Inc. | -12.69 Million USD | -2804.461% |
| Acrivon Therapeutics, Inc. Common Stock | -59.85 Million USD | -515.958% |
| Rigel Pharmaceuticals, Inc. | -16.98 Million USD | -2071.034% |
| Adicet Bio, Inc. | -136.53 Million USD | -170.014% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4943.206% |
| Quantum-Si incorporated | -91.8 Million USD | -301.576% |
| Acurx Pharmaceuticals, Inc. | - USD | Infinity% |
| Generation Bio Co. | -133.3 Million USD | -176.567% |
| Black Diamond Therapeutics, Inc. | -86.02 Million USD | -328.564% |
| Invivyd, Inc. | -196.61 Million USD | -87.505% |
| Relay Therapeutics, Inc. | -374.15 Million USD | 1.467% |
| Quoin Pharmaceuticals, Ltd. | -9.27 Million USD | -3874.893% |
| Moolec Science SA | -52.07 Million USD | -607.939% |
| Clearside Biomedical, Inc. | -23.05 Million USD | -1498.852% |
| Longboard Pharmaceuticals, Inc. | -56.75 Million USD | -549.581% |
| Relmada Therapeutics, Inc. | 4.91 Million USD | 7608.027% |
| ALX Oncology Holdings Inc. | -158.4 Million USD | -132.736% |
| Vir Biotechnology, Inc. | -684.3 Million USD | 46.126% |
| Evaxion Biotech A/S | -21.4 Million USD | -1622.484% |
| Ocular Therapeutix, Inc. | -66.41 Million USD | -455.09% |
| Tyra Biosciences, Inc. | -79.59 Million USD | -363.191% |
| Unity Biotechnology, Inc. | -37.28 Million USD | -888.824% |
| Connect Biopharma Holdings Limited | -58.37 Million USD | -531.576% |
| Clearmind Medicine Inc. | -8.71 Million USD | -4132.322% |
| Aadi Bioscience, Inc. | -65.36 Million USD | -464.007% |
| Catalyst Pharmaceuticals, Inc. | 86.81 Million USD | 524.669% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -15000.4% |
| Viking Therapeutics, Inc. | -100.82 Million USD | -265.639% |
| Keros Therapeutics, Inc. | -152.17 Million USD | -142.26% |
| Crinetics Pharmaceuticals, Inc. | -221.51 Million USD | -66.432% |
| ImmunityBio, Inc. | -436.18 Million USD | 15.479% |
| Korro Bio, Inc. | -80.9 Million USD | -355.68% |
| Kineta, Inc. | -15.71 Million USD | -2246.082% |
| BioVie Inc. | -31.95 Million USD | -1053.868% |
| Codexis, Inc. | -49.28 Million USD | -648.054% |
| Celularity Inc. | -183.94 Million USD | -100.419% |
| Virax Biolabs Group Limited | -6.6 Million USD | -5478.079% |
| Cibus, Inc. | -314.58 Million USD | -17.19% |
| Annexon, Inc. | -141.57 Million USD | -160.401% |
| Assembly Biosciences, Inc. | -64.19 Million USD | -474.278% |
| Eyenovia, Inc. | -24.1 Million USD | -1429.34% |
| Puma Biotechnology, Inc. | 44.78 Million USD | 923.203% |
| NeurAxis, Inc. | -6.66 Million USD | -5431.751% |
| Regulus Therapeutics Inc. | -30.88 Million USD | -1093.78% |
| Compass Therapeutics, Inc. | -48.47 Million USD | -660.554% |
| TFF Pharmaceuticals, Inc. | -20.74 Million USD | -1677.482% |
| Notable Labs, Ltd. | -14.4 Million USD | -2460.162% |
| IN8bio, Inc. | -28.5 Million USD | -1193.374% |
| DiaMedica Therapeutics Inc. | -19.3 Million USD | -1809.381% |
| Vera Therapeutics, Inc. | -102.01 Million USD | -261.392% |
| Lumos Pharma, Inc. | -36.57 Million USD | -908.103% |
| Liquidia Corporation | -70.05 Million USD | -426.278% |
| Mustang Bio, Inc. | -48.06 Million USD | -667.042% |
| Quantum-Si incorporated | -91.8 Million USD | -301.576% |
| Arbutus Biopharma Corporation | -70.98 Million USD | -419.346% |
| enGene Holdings Inc. Common Stock | -94.77 Million USD | -289.0% |
| ARS Pharmaceuticals, Inc. | -67.44 Million USD | -446.597% |
| 180 Life Sciences Corp. | -22.13 Million USD | -1565.595% |
| Vaxcyte, Inc. | -464.88 Million USD | 20.698% |
| Xenon Pharmaceuticals Inc. | -210.51 Million USD | -75.126% |
| Estrella Immunopharma, Inc. | -7.31 Million USD | -4943.206% |
| NKGen Biotech, Inc. Warrants | -28.54 Million USD | -1191.607% |
| Opiant Pharmaceuticals, Inc. | 5.82 Million USD | 6424.372% |
| CERo Therapeutics Holdings, Inc. | -2.44 Million USD | -15000.4% |
| Soleno Therapeutics, Inc. | -37.03 Million USD | -895.58% |
| PepGen Inc. | -83.58 Million USD | -341.08% |
| Moleculin Biotech, Inc. | -29.5 Million USD | -1149.537% |
| Solid Biosciences Inc. | -93.43 Million USD | -294.571% |
| Palisade Bio, Inc. | -12.28 Million USD | -2901.9% |
| Nutriband Inc. | -5.12 Million USD | -7097.957% |
| Conduit Pharmaceuticals Inc. | -324 Thousand USD | -113684.965% |
| Immuneering Corporation | -58.06 Million USD | -534.961% |
| Belite Bio, Inc | -31.52 Million USD | -1069.283% |
| CG Oncology, Inc. Common stock | -55.43 Million USD | -565.073% |
| GeoVax Labs, Inc. | -26.66 Million USD | -1282.378% |
| Tourmaline Bio, Inc. | -45.37 Million USD | -712.463% |
| Altimmune, Inc. | -87.93 Million USD | -319.245% |
| Peak Bio, Inc. | -1356.23 USD | -27182847.361% |
| SeaStar Medical Holding Corporation | -11.14 Million USD | -3209.068% |
| FibroBiologics, Inc. Common Stock | -15.9 Million USD | -2218.491% |
| Neurogene Inc. | -52.28 Million USD | -605.09% |
| Mirum Pharmaceuticals, Inc. | -136.49 Million USD | -170.103% |
| Kintara Therapeutics, Inc. | -8.39 Million USD | -4290.94% |
| CARGO Therapeutics, Inc. Common Stock | -93.01 Million USD | -296.335% |
| Sesen Bio, Inc. | -50.84 Million USD | -625.144% |
| argenx SE | -216.02 Million USD | -70.659% |
| NKGen Biotech, Inc. Common Stock | -28.54 Million USD | -1191.607% |
| Dianthus Therapeutics, Inc. | -48.17 Million USD | -665.274% |
| Immunome, Inc. | -28.27 Million USD | -1204.033% |
| Enveric Biosciences, Inc. | -17.13 Million USD | -2050.896% |
| Design Therapeutics, Inc. | -66.32 Million USD | -455.844% |
| Seelos Therapeutics, Inc. | -37.75 Million USD | -876.591% |
| Enliven Therapeutics, Inc. | -81.93 Million USD | -349.963% |
| Iovance Biotherapeutics, Inc. | -427.43 Million USD | 13.749% |
| Taysha Gene Therapies, Inc. | -105.19 Million USD | -250.45% |
| Inovio Pharmaceuticals, Inc. | -130.39 Million USD | -182.737% |
| Athira Pharma, Inc. | -116.7 Million USD | -215.899% |
| XOMA Corporation | -39.36 Million USD | -836.597% |
| Merus N.V. | -149.2 Million USD | -147.082% |
| Quince Therapeutics, Inc. | -31.26 Million USD | -1079.345% |
| Rezolute, Inc. | -68.42 Million USD | -438.8% |
| Clene Inc. | -43.24 Million USD | -752.578% |
| Indaptus Therapeutics, Inc. | -15.42 Million USD | -2290.473% |
| BeyondSpring Inc. | -21.54 Million USD | -1611.529% |
| Synlogic, Inc. | -55.16 Million USD | -568.34% |
| Allarity Therapeutics, Inc. | -12.08 Million USD | -2951.091% |
| Phio Pharmaceuticals Corp. | -10.64 Million USD | -3364.229% |
| Peak Bio, Inc. | -1356.23 USD | -27182847.361% |
| Werewolf Therapeutics, Inc. | -32.46 Million USD | -1035.571% |
| Krystal Biotech, Inc. | 17.9 Million USD | 2159.111% |
| Karyopharm Therapeutics Inc. | -118.42 Million USD | -211.311% |
| SpringWorks Therapeutics, Inc. | -341.34 Million USD | -8.003% |
| Lipella Pharmaceuticals Inc. | -4.6 Million USD | -7903.229% |
| MannKind Corporation | 15.12 Million USD | 2536.799% |
| Ikena Oncology, Inc. | -74.39 Million USD | -395.535% |
| Cyclerion Therapeutics, Inc. | -12.59 Million USD | -2827.526% |
| Gyre Therapeutics, Inc. | 20.32 Million USD | 1913.663% |
| Gossamer Bio, Inc. | -172.15 Million USD | -114.15% |
| CohBar, Inc. | -12.06 Million USD | -2955.45% |
| Cognition Therapeutics, Inc. | -25.5 Million USD | -1345.228% |
| NRx Pharmaceuticals, Inc. | -30.02 Million USD | -1127.854% |
| Legend Biotech Corporation | -477.87 Million USD | 22.853% |
| Mural Oncology plc | -192.72 Million USD | -91.295% |
| Disc Medicine, Inc. | -91.02 Million USD | -305.013% |
| Champions Oncology, Inc. | -5.05 Million USD | -7194.485% |
| REGENXBIO Inc. | -239.46 Million USD | -53.954% |
| Ensysce Biosciences, Inc. | -10.71 Million USD | -3339.605% |
| Anavex Life Sciences Corp. | -55.75 Million USD | -561.208% |
| Cellectar Biosciences, Inc. | -38.76 Million USD | -850.941% |
| Edgewise Therapeutics, Inc. | -112.8 Million USD | -226.812% |
| Vaxart, Inc. | -74.72 Million USD | -393.373% |
| PharmaCyte Biotech, Inc. | - USD | Infinity% |
| Aldeyra Therapeutics, Inc. | -35.2 Million USD | -947.092% |
| Cellectis S.A. | -98.09 Million USD | -275.823% |
| Longeveron Inc. | -20.06 Million USD | -1737.803% |
| Repare Therapeutics Inc. | -114.27 Million USD | -222.616% |
| Sarepta Therapeutics, Inc. | -439.19 Million USD | 16.06% |
| Inozyme Pharma, Inc. | -74.81 Million USD | -392.786% |
| Revolution Medicines, Inc. | -430.58 Million USD | 14.38% |
| Nymox Pharmaceutical Corporation | -6.28 Million USD | -5762.034% |
| Third Harmonic Bio, Inc. | -30.78 Million USD | -1097.386% |
| ArriVent BioPharma, Inc. Common Stock | -74.59 Million USD | -394.253% |
| AN2 Therapeutics, Inc. | 4.9 Million USD | 7619.137% |
| Anixa Biosciences, Inc. | -10.96 Million USD | -3262.182% |
| Vertex Pharmaceuticals Incorporated | 4.6 Billion USD | 108.005% |
| Denali Therapeutics Inc. | -179.97 Million USD | -104.844% |
| Revelation Biosciences, Inc. | -95.2 Thousand USD | -387118.812% |
| Veru Inc. | -89.97 Million USD | -309.737% |
| Corvus Pharmaceuticals, Inc. | -26.87 Million USD | -1271.617% |
| Cingulate Inc. | -22.95 Million USD | -1506.234% |
| Passage Bio, Inc. | -98.34 Million USD | -274.883% |
| Context Therapeutics Inc. | -25.06 Million USD | -1371.089% |
| Exicure, Inc. | -15.53 Million USD | -2272.503% |
| Day One Biopharmaceuticals, Inc. | -206.06 Million USD | -78.907% |
| Oramed Pharmaceuticals Inc. | -36.97 Million USD | -897.034% |
| Scinai Immunotherapeutics Ltd. | -5.96 Million USD | -6082.933% |
| Nuvalent, Inc. | -149.49 Million USD | -146.611% |
| ABVC BioPharma, Inc. | -8.13 Million USD | -4433.257% |
| Carisma Therapeutics, Inc. | -85.89 Million USD | -329.207% |
| Unicycive Therapeutics, Inc. | -30.17 Million USD | -1121.629% |
| OmniAb, Inc. | -49.73 Million USD | -641.315% |
| Anew Medical, Inc. | -1.3 Million USD | -28240.402% |
| Fennec Pharmaceuticals Inc. | -12.36 Million USD | -2881.748% |
| Lipocine Inc. | -16.32 Million USD | -2158.597% |
| Lexeo Therapeutics, Inc. Common Stock | -66.67 Million USD | -452.967% |
| Nautilus Biotechnology, Inc. | -74.3 Million USD | -396.162% |
| SAB Biotherapeutics, Inc. | -38.13 Million USD | -866.777% |
| G1 Therapeutics, Inc. | -39.01 Million USD | -844.951% |
| Bellerophon Therapeutics, Inc. | -22.18 Million USD | -1561.918% |
| Sage Therapeutics, Inc. | -545.07 Million USD | 32.364% |
| Ocugen, Inc. | -64.82 Million USD | -468.688% |
| Mind Medicine (MindMed) Inc. | -92.57 Million USD | -298.254% |
| Q32 Bio Inc. | -86.5 Million USD | -326.19% |
| Brainstorm Cell Therapeutics Inc. | -16.92 Million USD | -2077.96% |
| Alumis Inc. Common Stock | -156.89 Million USD | -134.982% |
| Equillium, Inc. | -12.13 Million USD | -2937.266% |
| Kyverna Therapeutics, Inc. | -58.47 Million USD | -530.495% |
| Coya Therapeutics, Inc. | -7.9 Million USD | -4564.646% |
| CNS Pharmaceuticals, Inc. | -18.86 Million USD | -1854.635% |
| Dominari Holdings Inc. | -22.44 Million USD | -1542.885% |
| Edesa Biotech, Inc. | -8.19 Million USD | -4401.305% |
| vTv Therapeutics Inc. | -25.41 Million USD | -1350.745% |
| Bio-Techne Corporation | 326.66 Million USD | 212.857% |
| Agios Pharmaceuticals, Inc. | -384.86 Million USD | 4.209% |
| Harmony Biosciences Holdings, Inc. | 216.38 Million USD | 270.371% |
| Prelude Therapeutics Incorporated | -131.1 Million USD | -181.191% |
| Candel Therapeutics, Inc. | -37.43 Million USD | -884.914% |
| iTeos Therapeutics, Inc. | -151.1 Million USD | -143.985% |
| Nkarta, Inc. | -120.48 Million USD | -205.993% |
| BioCardia, Inc. | -11.56 Million USD | -3089.129% |
| Iterum Therapeutics plc | -34.58 Million USD | -966.117% |